ICH E6(R3) Compliance Through QMS and MES Validation

ICH E6(R3) introduces a shift toward risk-based quality management, stronger data integrity, and updated validation expectations. As clinical trials become more digital and complex, organizations must align QMS, MES, and validation strategies to ensure compliance, improve oversight, and support reliable, high-quality data.
March 27, 2026
White Paper: ICH E6(R3) Compliance Through QMS and MES Validation

Comments

Leave a reply. Your email address will not be published. Required fields are marked *
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

ICH E6(R3) Compliance Through QMS and MES Validation

ICH E6(R3) introduces a shift toward risk-based quality management, stronger data integrity, and updated validation expectations. As clinical trials become more digital and complex, organizations must align QMS, MES, and validation strategies to ensure compliance, improve oversight, and support reliable, high-quality data.

ICH E6(R3) introduces a shift toward risk-based quality management, stronger data integrity, and updated validation expectations. As clinical trials become more digital and complex, organizations must align QMS, MES, and validation strategies to ensure compliance, improve oversight, and support reliable, high-quality data.

Start Date
End Date
Event Location
Webinar

5 Things You Can Improve During Instrument Qualifications

White Paper

5 Things You Can Improve During Instrument Qualifications

eBooks

This is an e-book title

Case Study

This is a case study title

Video

This is a video title